Summary
The global Antifungal Drugs Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
These various types of antifungals are available for the treatment of fungal infections. An antifungal drug, clotrimazole, is available in various types. The various types are available in tablet, liquid, suppository, and gels. Capsules are particularly effective, as they are larger and last longer. Most of the antifungals are available without a prescription in most parts of the United States.
Market Dynamics
High prevalence of fungal infections is expected to propel growth of the antifungal drugs market over the forecast period. For instance, annually, over 150 million severe cases of fungal infections occur worldwide, resulting in approximately 1.7 million deaths per year.
Emergence of Covid-19 is also expected to aid in growth of the antifungal drugs market. Globally, as of 5:09 pm CEST, 20 October 2021, there have been 241,411,380 confirmed cases of COVID-19, including 4,912,112 deaths, reported to WHO. As of 19 October 2021, a total of 6,545,309,084 vaccine doses have been administered. In April 2021, research published in the British Journal of Pharmacology reported that antifungal itraconazole and the antidepressant fluoxetine can effectively inhibit the virus that causes COVID-19 in laboratory cells.
Inclusion of antifungal drugs in lists of essential medicines is expected to offer lucrative growth opportunities for players in the antifungal drugs market. For instance, in October 2021, The World Health Organization included new drugs for treatments of cancer and diabetes, antimicrobials, antifungal drugs and tobacco cessation medicines in the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children.
Major players operating in the antifungal drugs market are focused on approval and launch of new products to expand their product portfolio. For instance, in September 2021, SCYNEXIS, Inc. announced the availability of BREXAFEMME (ibrexafungerp tablets), an oral non-azole antifungal medication in the U.S for the treatment of vulvovaginal candidiasis.
Key Takeaways
- High prevalence of fungal infections is expected to propel growth of the antifungal drugs market over the forecast period
- Major players operating in the antifungal drugs market are focused on approval and launch of new products to expand their product portfolio. For instance, in October 2021, Intas Pharmaceuticals Limited launched Super Bioavailable Itraconazole-SB 100mg, an antifungal drug, under the brand name - Itaspor-SB Forte/Subawin.
- Major players operating in the antifungal drugs market include, Novartis AG, Pfizer, Inc., Sanofi, Merck, Enzon Pharmaceuticals, Bayer AG, Astellas Pharma, GlaxoSmithKline, Abbott Laboratories, J & J, Teva, and Mylan
The Antifungal Drugs Market report highlights product development and growth strategies such as mergers and acquisitions adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Antifungal Drugs Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Novartis
- Pfizer
- Sanofi
- Merck
- Enzon Pharmaceuticals
- Bayer
- Astellas Pharma
- GlaxoSmithKline
- Abbott
- J & J
- Teva
- Mylan
By Product Type, the market is primarily segmented into:
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Others
By Applications, the market is segmented into:
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Others
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Antifungal Drugs Market Report:
- To assess the size of the market by value and volume
- Analyze the Antifungal Drugs Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Antifungal Drugs Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Antifungal Drugs Market
The Antifungal Drugs Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Antifungal Drugs Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
1 Antifungal Drugs Market Overview
1.1 Antifungal Drugs Product Overview
1.2 Antifungal Drugs Market Segment by Type
1.2.1 Azoles
1.2.2 Echinocandins
1.2.3 Polyenes
1.2.4 Allylamines
1.2.5 Others
1.3 Global Antifungal Drugs Market Size by Type
1.3.1 Global Antifungal Drugs Sales and Growth by Type
1.3.2 Global Antifungal Drugs Sales and Market Share by Type
1.3.3 Global Antifungal Drugs Revenue and Market Share by Type
1.3.4 Global Antifungal Drugs Price by Type
1.4 North America Antifungal Drugs by Type
1.5 Europe Antifungal Drugs by Type
1.6 South America Antifungal Drugs by Type
1.7 Middle East and Africa Antifungal Drugs by Type
2 Global Antifungal Drugs Market Competition by Company
2.1 Global Antifungal Drugs Sales and Market Share by Company (2014-2019)
2.2 Global Antifungal Drugs Revenue and Share by Company (2014-2019)
2.3 Global Antifungal Drugs Price by Company (2014-2019)
2.4 Global Top Players Antifungal Drugs Manufacturing Base Distribution, Sales Area, Product Types
2.5 Antifungal Drugs Market Competitive Situation and Trends
2.5.1 Antifungal Drugs Market Concentration Rate
2.5.2 Global Antifungal Drugs Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Antifungal Drugs Company Profiles and Sales Data
3.1 Novartis
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Antifungal Drugs Product Category, Application and Specification
3.1.3 Novartis Antifungal Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Pfizer
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Antifungal Drugs Product Category, Application and Specification
3.2.3 Pfizer Antifungal Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Sanofi
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Antifungal Drugs Product Category, Application and Specification
3.3.3 Sanofi Antifungal Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Merck
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Antifungal Drugs Product Category, Application and Specification
3.4.3 Merck Antifungal Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Enzon Pharmaceuticals
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Antifungal Drugs Product Category, Application and Specification
3.5.3 Enzon Pharmaceuticals Antifungal Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Bayer
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Antifungal Drugs Product Category, Application and Specification
3.6.3 Bayer Antifungal Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Astellas Pharma
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Antifungal Drugs Product Category, Application and Specification
3.7.3 Astellas Pharma Antifungal Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 GlaxoSmithKline
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Antifungal Drugs Product Category, Application and Specification
3.8.3 GlaxoSmithKline Antifungal Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Abbott
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Antifungal Drugs Product Category, Application and Specification
3.9.3 Abbott Antifungal Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 J & J
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Antifungal Drugs Product Category, Application and Specification
3.10.3 J & J Antifungal Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 Teva
3.12 Mylan
4 Antifungal Drugs Market Status and Outlook by Regions
4.1 Global Antifungal Drugs Market Status and Outlook by Regions
4.1.1 Global Antifungal Drugs Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Europe
4.1.4 Asia-Pacific
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Antifungal Drugs Sales and Revenue by Regions
4.2.1 Global Antifungal Drugs Sales Market Share by Regions (2014-2019)
4.2.2 Global Antifungal Drugs Revenue Market Share by Regions (2014-2019)
4.2.3 Global Antifungal Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Antifungal Drugs Sales, Revenue, Price and Gross Margin
4.3.1 North America Antifungal Drugs Sales by Countries
4.3.2 United States
4.3.3 Canada
4.3.4 Mexico
4.4 Europe Antifungal Drugs Sales, Revenue, Price and Gross Margin
4.4.1 Europe Antifungal Drugs Sales by Countries
4.4.2 Germany
4.4.3 France
4.4.4 UK
4.4.5 Italy
4.4.6 Russia
4.5 Asia-Pacific Antifungal Drugs Sales, Revenue, Price and Gross Margin
4.5.1 Asia-Pacific Antifungal Drugs Sales by Regions
4.5.2 China
4.5.3 Japan
4.5.4 South Korea
4.5.5 India
4.5.6 Australia
4.5.7 Indonesia
4.5.8 Thailand
4.5.9 Malaysia
4.5.10 Philippines
4.5.11 Vietnam
4.6 South America Antifungal Drugs Sales, Revenue, Price and Gross Margin
4.6.1 South America Antifungal Drugs Sales by Countries
4.6.2 Brazil
4.7 Middle East and Africa Antifungal Drugs Sales, Revenue, Price and Gross Margin
4.7.1 Middle East and Africa Antifungal Drugs Sales by Countries
4.7.2 Turkey
4.7.3 GCC Countries
4.7.4 Egypt
4.7.5 South Africa
5 Antifungal Drugs Application
5.1 Antifungal Drugs Segment by Application
5.1.1 Dermatophytosis
5.1.2 Aspergillosis
5.1.3 Candidiasis
5.1.4 Others
5.2 Global Antifungal Drugs Product Segment by Application
5.2.1 Global Antifungal Drugs Sales by Application
5.2.2 Global Antifungal Drugs Sales and Market Share by Application (2014-2019)
5.3 North America Antifungal Drugs by Application
5.4 Europe Antifungal Drugs by Application
5.5 Asia-Pacific Antifungal Drugs by Application
5.6 South America Antifungal Drugs by Application
5.7 Middle East and Africa Antifungal Drugs by Application
6 Global Antifungal Drugs Market Forecast
6.1 Global Antifungal Drugs Sales, Revenue Forecast (2019-2025)
6.1.1 Global Antifungal Drugs Sales and Growth Rate Forecast (2019-2025)
6.1.2 Global Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Antifungal Drugs Forecast by Regions
6.2.1 North America Antifungal Drugs Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Antifungal Drugs Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Antifungal Drugs Sales and Revenue Forecast (2019-2025)
6.2.4 South America Antifungal Drugs Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Antifungal Drugs Sales and Revenue Forecast (2019-2025)
6.3 Antifungal Drugs Forecast by Type
6.3.1 Global Antifungal Drugs Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Azoles Growth Forecast
6.3.3 Echinocandins Growth Forecast
6.4 Antifungal Drugs Forecast by Application
6.4.1 Global Antifungal Drugs Sales Forecast by Application (2019-2025)
6.4.2 Global Antifungal Drugs Forecast in Dermatophytosis
6.4.3 Global Antifungal Drugs Forecast in Aspergillosis
7 Antifungal Drugs Upstream Raw Materials
7.1 Antifungal Drugs Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Antifungal Drugs Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Sales Channel
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Table
List of Tables and Figures
Figure Antifungal Drugs Product Picture
Figure Global Antifungal Drugs Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Antifungal Drugs Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Azoles
Table Major Players of Azoles
Figure Global Azoles Sales (K Units) and Growth Rate (2014-2019)
Figure Product Picture of Echinocandins
Table Major Players of Echinocandins
Figure Global Echinocandins Sales (K Units) and Growth Rate (2014-2019)
Figure Product Picture of Polyenes
Table Major Players of Polyenes
Figure Global Polyenes Sales (K Units) and Growth Rate (2014-2019)
Figure Product Picture of Allylamines
Table Major Players of Allylamines
Figure Global Allylamines Sales (K Units) and Growth Rate (2014-2019)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Units) and Growth Rate (2014-2019)
Table Global Antifungal Drugs Sales (K Units) and Growth Rate Comparison by Type (K Units)
Table Global Antifungal Drugs Sales (K Units) by Type (2014-2019) (K Units)
Table Global Antifungal Drugs Sales Share by Type (2014-2019)
Figure Global Antifungal Drugs Sales Market Share by Type (2014-2019)
Figure Global Antifungal Drugs Sales Market Share by Type in 2018
Table Global Antifungal Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Antifungal Drugs Revenue Share by Type (2014-2019)
Figure Global Antifungal Drugs Revenue Share by Type (2014-2019)
Figure Global Antifungal Drugs Revenue Market Share by Type in 2018
Table Global Antifungal Drugs Price (USD/Unit) by Type (2014-2019)
Table North America Antifungal Drugs Sales (USD/Unit) by Type (2014-2019)
Figure North America Antifungal Drugs Sales Market Share by Type in 2018
Table Europe Antifungal Drugs Sales (USD/Unit) by Type (2014-2019)
Figure Europe Antifungal Drugs Sales Market Share by Type in 2018
Table Asia-Pacific Antifungal Drugs Sales (USD/Unit) by Type (2014-2019)
Figure Asia-Pacific Antifungal Drugs Sales Market Share by Type in 2018
Table South America Antifungal Drugs Sales (USD/Unit) by Type (2014-2019)
Figure South America Antifungal Drugs Sales Market Share by Type in 2018
Table Middle East and Africa Antifungal Drugs Sales (USD/Unit) by Type (2014-2019)
Figure Middle East and Africa Antifungal Drugs Sales Market Share by Type in 2018
Table Global Antifungal Drugs Sales (K Units) by Company (2014-2019)
Table Global Antifungal Drugs Sales Share by Company (2014-2019)
Figure Global Antifungal Drugs Sales Share by Company in 2018
Table Global Antifungal Drugs Revenue (Million US$) by Company (2014-2019)
Table Global Antifungal Drugs Revenue Share by Company (2014-2019)
Figure Global Antifungal Drugs Revenue Share by Company in 2018
Table Global Market Antifungal Drugs Average Price (USD/Unit) by Company (2014-2019)
Table Global Antifungal Drugs Top Company Manufacturing Base Distribution and Sales Area
Table Global Antifungal Drugs Top Manufacturers Product Category
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) 15
Figure Global Antifungal Drugs Market Share of Top 5 Company
Figure Global Antifungal Drugs Market Share of Top 10 Company
Table Mergers & Acquisitions, Expansion Plans
Table Novartis Basic Information List
Table Novartis Antifungal Drugs Product Category, Application and Specification
Table Novartis Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Novartis Description and Business Overview
Table Pfizer Basic Information List
Table Pfizer Antifungal Drugs Product Category, Application and Specification
Table Pfizer Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Pfizer Description and Business Overview
Table Sanofi Basic Information List
Table Sanofi Antifungal Drugs Product Category, Application and Specification
Table Sanofi Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Sanofi Description and Business Overview
Table Merck Basic Information List
Table Merck Antifungal Drugs Product Category, Application and Specification
Table Merck Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Merck Description and Business Overview
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Antifungal Drugs Product Category, Application and Specification
Table Enzon Pharmaceuticals Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Enzon Pharmaceuticals Description and Business Overview
Table Bayer Basic Information List
Table Bayer Antifungal Drugs Product Category, Application and Specification
Table Bayer Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Bayer Description and Business Overview
Table Astellas Pharma Basic Information List
Table Astellas Pharma Antifungal Drugs Product Category, Application and Specification
Table Astellas Pharma Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Astellas Pharma Description and Business Overview
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antifungal Drugs Product Category, Application and Specification
Table GlaxoSmithKline Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Description and Business Overview
Table Abbott Basic Information List
Table Abbott Antifungal Drugs Product Category, Application and Specification
Table Abbott Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Abbott Description and Business Overview
Table J & J Basic Information List
Table J & J Antifungal Drugs Product Category, Application and Specification
Table J & J Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure J & J Description and Business Overview
Table Teva Basic Information List
Table Mylan Basic Information List
Table Global Antifungal Drugs Market Size Comparison by Regions (2014-2025) (K Units) & (Million US$)
Figure North America Antifungal Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Asia-Pacific Antifungal Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Antifungal Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure South America Antifungal Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Figure Middle East and Africa Antifungal Drugs Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Antifungal Drugs Sales (K Units) by Regions (2014-2019)
Table Global Antifungal Drugs Sales Market Share by Regions (2014-2019)
Figure Global Antifungal Drugs Sales Market Share by Regions (2014-2019)
Figure 2018 Global Antifungal Drugs Sales Market Share by Regions
Table Global Antifungal Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Antifungal Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Antifungal Drugs Revenue Market Share by Regions (2014-2019)
Figure 2018 Global Antifungal Drugs Revenue Market Share by Regions
Table Global Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure North America Antifungal Drugs Sales Growth Rate
Table North America Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure United States Antifungal Drugs Sales (K Units)(2014-2019)
Figure United States Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Canada Antifungal Drugs Sales (K Units)(2014-2019)
Figure Canada Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Mexico Antifungal Drugs Sales (K Units)(2014-2019)
Figure Mexico Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Europe Antifungal Drugs Sales Growth Rate
Table Europe Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Germany Antifungal Drugs Sales (K Units)(2014-2019)
Figure Germany Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure France Antifungal Drugs Sales (K Units)(2014-2019)
Figure France Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure UK Antifungal Drugs Sales (K Units)(2014-2019)
Figure UK Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Italy Antifungal Drugs Sales (K Units)(2014-2019)
Figure Italy Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Russia Antifungal Drugs Sales (K Units)(2014-2019)
Figure Russia Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Antifungal Drugs Sales Growth Rate
Table Asia-Pacific Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure China Antifungal Drugs Sales (K Units)(2014-2019)
Figure China Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Japan Antifungal Drugs Sales (K Units)(2014-2019)
Figure Japan Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure South Korea Antifungal Drugs Sales (K Units)(2014-2019)
Figure South Korea Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure India Antifungal Drugs Sales (K Units)(2014-2019)
Figure India Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Australia Antifungal Drugs Sales (K Units)(2014-2019)
Figure Australia Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Indonesia Antifungal Drugs Sales (K Units)(2014-2019)
Figure Indonesia Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Thailand Antifungal Drugs Sales (K Units)(2014-2019)
Figure Thailand Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Malaysia Antifungal Drugs Sales (K Units)(2014-2019)
Figure Malaysia Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Philippines Antifungal Drugs Sales (K Units)(2014-2019)
Figure Philippines Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Vietnam Antifungal Drugs Sales (K Units)(2014-2019)
Figure Vietnam Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure South America Antifungal Drugs Sales Growth Rate
Table South America Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Brazil Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Brazil Antifungal Drugs Sales (K Units)(2014-2019)
Figure Middle East and Africa Antifungal Drugs Sales Growth Rate
Table Middle East and Africa Antifungal Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Turkey Antifungal Drugs Sales (K Units)(2014-2019)
Figure Turkey Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure GCC Countries Antifungal Drugs Sales (K Units)(2014-2019)
Figure GCC Countries Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Egypt Antifungal Drugs Sales (K Units)(2014-2019)
Figure Egypt Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure South Africa Antifungal Drugs Sales (K Units)(2014-2019)
Figure South Africa Antifungal Drugs Revenue (Million USD)(2014-2019)
Figure Dermatophytosis Examples
Figure Aspergillosis Examples
Figure Candidiasis Examples
Figure Others Examples
Table Global Antifungal Drugs Sales (K Units) Comparison by Application (2014-2025)
Table Global Antifungal Drugs Sales (K Units) by Application (2014-2019)
Table Global Antifungal Drugs Sales Share by Application (2014-2019)
Figure Global Antifungal Drugs Sales Market Share by Application (2014-2019)
Figure Global Antifungal Drugs Sales Market Share by Application in 2018
Figure Global Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Global Antifungal Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Antifungal Drugs Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Antifungal Drugs Sales Market Share Forecast by Regions (2019-2025)
Figure North America Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure North America Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Europe Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Europe Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Asia-Pacific Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Asia-Pacific Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure China Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure China Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Japan Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Japan Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure South Korea Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure South Korea Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure India Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure India Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Australia Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Australia Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Indonesia Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Indonesia Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure South America Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure South America Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Middle East & Africa Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Middle East & Africa Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Turkey Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Turkey Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure GCC Countries Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure GCC Countries Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure Egypt Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure Egypt Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Figure South Africa Antifungal Drugs Sales (K Units) and Growth Rate Forecast (2019-2025)
Figure South Africa Antifungal Drugs Revenue and Growth Rate Forecast (2019-2025)
Table Global Antifungal Drugs Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Antifungal Drugs Sales Market Share Forecast by Type (2019-2025)
Table Global Antifungal Drugs Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Antifungal Drugs Revenue Market Share Forecast by Type (2019-2025)
Figure Azoles Sales Growth Forecast
Figure Echinocandins Sales Growth Forecast
Table Global Antifungal Drugs Sales (K Units) Forecast by Application (2019-2025)
Figure Global Antifungal Drugs Sales Forecast by Application (2019-2025)
Figure Global Antifungal Drugs Sales (K Units) Forecast in Dermatophytosis
Figure Global Antifungal Drugs Sales (K Units) Forecast in Aspergillosis
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Antifungal Drugs Manufacturing Cost Structure
Figure Antifungal Drugs Industrial Chain Analysis
Table Distributors List
Table Antifungal Drugs Downstream Customers
Table Research Programs/Design for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Request Discount 
Inquire Before Buy
